Cargando…
Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation
In this commentary, we summarize the most recent advances in the cytokine-targeting therapies. We focus on new aspects of interleukin-1 (IL-1)-mediated autoinflammation and novel strategies to target IL-1.
Autores principales: | Kalliolias, George D, Ivashkiv, Lionel B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biology Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948254/ https://www.ncbi.nlm.nih.gov/pubmed/20948617 http://dx.doi.org/10.3410/B1-70 |
Ejemplares similares
-
Synovial fibroblasts display an uncontrolled inflammatory and tissue destructive response to TNF-α
por: Kalliolias, George D, et al.
Publicado: (2012) -
Overview of the biology of type I interferons
por: Kalliolias, George D, et al.
Publicado: (2010) -
Pathogenesis of Psoriasis: Focus on Autoinflammation
por: Marzano, Angelo Valerio, et al.
Publicado: (2018) -
Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade
por: DeSena, Allen D., et al.
Publicado: (2018) -
Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
por: Padoan, Andrea, et al.
Publicado: (2023)